glp-1 aurora Weight Loss Options ASMS 2026 | BioPharma |

user base of anti-obesity medications (such as GLP-1RAs) to be c.5m users and expects this to grow to c.24m by 2035, while Goldman Sachs5 projects c.15m U.S

That's according to the National Institute of Diabetes and Digestive and Kidney Diseases

Materials and methods Antibodies and reagents PC2 antibody (D1E1S), t-PKA antibody (D38C6), p-PKA antibody (D45D3), Pdx1 antibody (D59H3), GLP-1R antibody (HA500204) and all secondary antibodies used in Western blot were purchased from Cell Signaling Technology (Beverly, MA, United States)

[DOI] [PubMed] [Google Scholar] 54.Latif W, Lambrinos KJ, Rodriguez R

E., Gishan, F